Research Article
Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin in Pig against Korean Local Isolates of Actinobacillus pleuropneumoniae
Table 4
The pharmacodynamic parameters of marbofloxacin against 20 isolates of Actinobacillus pleuropneumonia.
| Strain number | Concentration range (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | MBC/MIC |
| 1 | 32–0.00391 | 0.0625 | 0.0625 | 1 | 2 | 32–0.00391 | 0.0625 | 0.25 | 4 | 3 | 32–0.00391 | 0.125 | 0.125 | 1 | 4 | 32–0.00391 | 0.125 | 0.125 | 1 | 5 | 32–0.00391 | 0.0625 | 0.5 | 8 | 6 | 32–0.00391 | 0.125 | 0.25 | 2 | 7 | 32–0.00391 | 0.125 | 1 | 8 | 8 | 32–0.00391 | 0.125 | 0.25 | 2 | 9 | 32–0.00391 | 0.125 | 0.25 | 2 | 10 | 32–0.00391 | 0.0625 | 0.0625 | 1 | 11 | 32–0.00391 | 0.5 | 2 | 4 | 12 | 32–0.00391 | 0.5 | 2 | 4 | 13 | 32–0.00391 | 0.0625 | 0.25 | 4 | 14 | 32–0.00391 | 0.125 | 0.125 | 1 | 15 | 32–0.00391 | 0.25 | 2 | 8 | 16 | 32–0.00391 | 0.125 | 0.25 | 2 | 17 | 32–0.00391 | 0.0313 | 0.0625 | 2 | 18 | 32–0.00391 | 0.0625 | 0.0625 | 1 | 19 | 32–0.00391 | 1 | 8 | 8 | 20 | 32–0.00391 | 0.25 | 4 | 16 |
|
|